The event will focus on EscharEx, an innovative biologic drug in late-stage development for chronic wound debridement, specifically targeting Venous Leg Ulcers (VLUs). The event will feature three ...
The biologic therapy, injected below the skin, is being developed to promote healing of venous leg ulcers (VLUs ... failed to respond to conventional wound care. Merakris is targeting late ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback